<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>200119</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11035079</PubmedId>
            <Abstract>We have sequenced the Pan troglodytes class I (Patr) molecules from three common chimpanzees and expressed them as single molecules in a class I-deficient cell line. These lines were utilized to obtain purified class I molecules to define the peptide binding motifs associated with five different Patr molecules. Based on these experiments, as well as analysis of the predicted structure of the B and F polymorphic MHC pockets, we classified five Patr molecules (Patr-A*0101, Patr-B*0901, Patr-B*0701, Patr-A*0602, and Patr-B*1301) within previously defined supertype specificities associated with HLA class I molecules (HLA-A3, -B7, -A1, and -A24 supertypes). The overlap in the binding repertoire between specific HLA and Patr class I molecules was in the range of 33 to 92%, depending on the particular Patr molecule as assessed by the binding of HIV-, hepatitis B virus-, and hepatitis C virus-derived epitopes. Finally, live cell binding assays of nine chimpanzee-derived B cell lines demonstrated that HLA supertype peptides bound to Patr class I molecules with frequencies in the 20-50% range.</Abstract>
            <ArticleYear>2000</ArticleYear>
            <ArticlePages>4414-22</ArticlePages>
            <ArticleTitle>Identification of five different Patr class I molecules that bind HLA supertype peptides and definition of their peptide binding motifs.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>McKinney</LastName>
                    <ForeName>D M</ForeName>
                </Author>
                <Author>
                    <LastName>Erickson</LastName>
                    <ForeName>A L</ForeName>
                </Author>
                <Author>
                    <LastName>Walker</LastName>
                    <ForeName>C M</ForeName>
                </Author>
                <Author>
                    <LastName>Thimme</LastName>
                    <ForeName>R</ForeName>
                </Author>
                <Author>
                    <LastName>Chisari</LastName>
                    <ForeName>F V</ForeName>
                </Author>
                <Author>
                    <LastName>Sidney</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Sette</LastName>
                    <ForeName>A</ForeName>
                </Author>
            </Authors>
            <Affiliations>Epimmune Inc., San Diego, CA 92121, USA. dmckinney@epimmune.com.</Affiliations>
            <ArticleChemicalList>HLA Antigens;HLA-A1 Antigen;HLA-A3 Antigen;HLA-B Antigens;HLA-B7 Antigen;Histocompatibility Antigens Class I;Oligopeptides</ArticleChemicalList>
            <ArticleMeshHeadingsList>Alleles; Amino Acid Motifs(genetics; immunology); Animals; B-Lymphocytes(metabolism); Cell Line, Transformed; Genes, MHC Class I; HLA Antigens(metabolism); HLA-A1 Antigen(genetics; metabolism); HLA-A3 Antigen(genetics; metabolism); HLA-B Antigens(genetics; metabolism); HLA-B7 Antigen(genetics; metabolism); Histocompatibility Antigens Class I(genetics; isolation &amp; purification; metabolism); Humans; Oligopeptides(chemical synthesis; immunology; metabolism); Pan troglodytes(genetics; immunology); Protein Binding(genetics; immunology); Sequence Analysis, DNA; Transfection</ArticleMeshHeadingsList>
            <Journal>
                <Volume>165</Volume>
                <Issue>8</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Pol 541 (541-549)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FPHCLAFSY</LinearSequence>
                        <StartingPosition>541</StartingPosition>
                        <EndingPosition>549</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA53358.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 6</LocationOfData>
                <EpitopeId>17303</EpitopeId>
                <ReferenceStartingPosition>541</ReferenceStartingPosition>
                <ReferenceEndingPosition>549</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Data originally imported from TopBank (LIAI internal MHC binding database) and recurated.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206334</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>251</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206335</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>545.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol 530 (530-539)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FPHCLAFSYM</LinearSequence>
                        <StartingPosition>530</StartingPosition>
                        <EndingPosition>539</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA46356.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 6</LocationOfData>
                <EpitopeId>17304</EpitopeId>
                <ReferenceStartingPosition>530</ReferenceStartingPosition>
                <ReferenceEndingPosition>539</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Data originally imported from TopBank (LIAI internal MHC binding database) and recurated.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206336</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>56.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>251</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206337</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>40.9</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol 429 (429-437)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HPAAMPHLL</LinearSequence>
                        <StartingPosition>429</StartingPosition>
                        <EndingPosition>437</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA46356.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 6</LocationOfData>
                <EpitopeId>24420</EpitopeId>
                <ReferenceStartingPosition>429</ReferenceStartingPosition>
                <ReferenceEndingPosition>437</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Data originally imported from TopBank (LIAI internal MHC binding database) and recurated.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206338</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>56.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>251</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206339</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>15.7</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Env 313 (313-321)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IPIPSSWAF</LinearSequence>
                        <StartingPosition>313</StartingPosition>
                        <EndingPosition>321</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>BAA85374.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 6</LocationOfData>
                <EpitopeId>27878</EpitopeId>
                <ReferenceStartingPosition>313</ReferenceStartingPosition>
                <ReferenceEndingPosition>321</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Data originally imported from TopBank (LIAI internal MHC binding database) and recurated.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206341</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.5</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206340</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>42.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>251</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Core 19 (19-27)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LPSDFFPSV</LinearSequence>
                        <StartingPosition>19</StartingPosition>
                        <EndingPosition>27</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAL31859.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 6</LocationOfData>
                <EpitopeId>38701</EpitopeId>
                <ReferenceStartingPosition>19</ReferenceStartingPosition>
                <ReferenceEndingPosition>27</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Data originally imported from TopBank (LIAI internal MHC binding database) and recurated.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206343</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>29.1</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206342</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>1774.0</QuantitativeMeasurement>
                            <AssayComments>The authors consider &gt;500 nM to represent a non- binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>251</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>X 58</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LPVCAPSSA</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC279984</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 6</LocationOfData>
                <EpitopeId>38746</EpitopeId>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Data originally imported from TopBank (LIAI internal MHC binding database) and recurated.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206344</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>115.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>251</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206345</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.6</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol 640 (640-647)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YPALMPLY</LinearSequence>
                        <StartingPosition>640</StartingPosition>
                        <EndingPosition>647</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA46356.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 6</LocationOfData>
                <EpitopeId>75256</EpitopeId>
                <ReferenceStartingPosition>640</ReferenceStartingPosition>
                <ReferenceEndingPosition>647</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Data originally imported from TopBank (LIAI internal MHC binding database) and recurated.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206346</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>251</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206347</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>209.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol 640 (640-648)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YPALMPLYA</LinearSequence>
                        <StartingPosition>640</StartingPosition>
                        <EndingPosition>648</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA46356.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 6</LocationOfData>
                <EpitopeId>75257</EpitopeId>
                <ReferenceStartingPosition>640</ReferenceStartingPosition>
                <ReferenceEndingPosition>648</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Data originally imported from TopBank (LIAI internal MHC binding database) and recurated.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206348</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>306.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>251</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206349</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8.4</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pol 640 (640-650)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YPALMPLYACI</LinearSequence>
                        <StartingPosition>640</StartingPosition>
                        <EndingPosition>650</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA46356.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 6</LocationOfData>
                <EpitopeId>75258</EpitopeId>
                <ReferenceStartingPosition>640</ReferenceStartingPosition>
                <ReferenceEndingPosition>650</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Data originally imported from TopBank (LIAI internal MHC binding database) and recurated.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206351</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>361.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>206350</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>1375.0</QuantitativeMeasurement>
                            <AssayComments>The authors consider &gt;500 nM to represent a non- binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>251</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFPYALINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>34009</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1324632</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The Patr-B*1301 class I molecule does not bind to the epitope, which is a prototype HLA -A3 supertype binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <MhcBindingId>1324630</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.7</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1324634</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The Patr-A*0701 class I molecule does not bind to the epitope, which is a prototype HLA -A3 supertype binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1324631</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The Patr-B*0901 class I molecule does not bind to the epitope, which is a prototype HLA -A3 supertype binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YTAVVPLVY</LinearSequence>
                        <StartingPosition>110</StartingPosition>
                        <EndingPosition>118</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P01591.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>75980</EpitopeId>
                <ReferenceStartingPosition>102</ReferenceStartingPosition>
                <ReferenceEndingPosition>110</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324702</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.4</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1324648</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The Patr-A*0701 class I molecule does not bind to the epitope, which is a prototype HLA -A3 supertype binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1324647</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The Patr-A*0101 class I molecule does not bind to the epitope, which is a prototype HLA -A3 supertype binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1324645</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The Patr-B*1301 class I molecule does not bind to the epitope, which is a prototype HLA -A3 supertype binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figures 1 and 3</LocationOfData>
                        <MhcBindingId>1324646</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6.4</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>3801</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is an analogue of a HLA-B*0702 naturally processed peptide with a Leu to Tyr substitution at position 7.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figures 1 and 4</LocationOfData>
                        <MhcBindingId>1324651</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.3</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1324650</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The Patr-B*0901 class I molecule does not bind to the epitope, which is a prototype HLA -A3 supertype binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1324652</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The Patr-A*0701 class I molecule does not bind to the epitope, which is a prototype HLA -A3 supertype binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1324649</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The Patr-A*0101 class I molecule does not bind to the epitope, which is a prototype HLA -A3 supertype binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>5807</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1324654</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The Patr-B*1301 class I molecule does not bind to the epitope, which is a prototype HLA -A3 supertype binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figures 1 and 4</LocationOfData>
                        <MhcBindingId>1324655</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>164.4</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1324653</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The Patr-A*0101 class I molecule does not bind to the epitope, which is a prototype HLA -A3 supertype binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1324656</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>296</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The Patr-B*0901 class I molecule does not bind to the epitope, which is a prototype HLA -A3 supertype binder.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P1-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>DVFPYALINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>10593</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324658</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 1 of the prototype peptide (KVPYALINK; 0.7 nM) which reduces binding of the Patr-A*0101 class I molecule less than 10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324663</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 1 of the prototype peptide (KVPYALINK; 0.7 nM) which reduces binding to the HLA-A*0301 class I molecule 100-fold.  Position 1 is a secondary anchor residue for HLA-A*0301.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P2-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KFFPYALINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>30727</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324664</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 2 of the prototype peptide (KVPYALINK; 0.7 nM) which increases binding to the Patr A*0101 class I molecule almost 10-fold. Position 2 is defined as a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324665</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 2 of the prototype peptide (KVPYALINK; 0.7 nM) which increases binding to the HLA A*0301 class I molecule almost 10-fold. Position 2 is defined as a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P2-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KAFPYALINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>29800</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324667</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 2 of the prototype peptide (KVPYALINK; 0.7 nM) which increases binding to the HLA A*0301 class I molecule &lt;10-fold. Position 2 is defined as a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324666</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 2 of the prototype peptide (KVPYALINK; 0.7 nM) which increases binding to the Patr A*0101 class I molecule &lt;10-fold. Position 2 is defined as a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P2-L)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KLFPYALINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>31860</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324668</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 2 of the prototype peptide (KVPYALINK; 0.7 nM) which increases binding to the Patr A*0101 class I molecule &lt;10-fold. Position 2 is defined as a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324669</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 2 of the prototype peptide (KVPYALINK; 0.7 nM) which increases binding to the HLA A*0301 class I molecule &gt;10-fold. Position 2 is defined as a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P2-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KKFPYALINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>31542</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324670</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 2 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the Patr A*0101 class I molecule. Position 2 is defined as a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324671</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 2 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the HLA-A*0301 class I molecule about 1000-fold. Position 2 is defined as a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P2-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KNFPYALINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>32495</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324672</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 2 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding slightly to the Patr A*0101 class I molecule. Position 2 is defined as a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324673</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 2 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the HLA-A*0301 class I molecule &lt;10-fold. Position 2 is defined as a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P2-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KDFPYALINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>30148</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324674</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 2 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the Patr A*0101 class I molecule &gt;10-fold. Position 2 is defined as a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324675</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 2 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the HLA-A*0301 class I molecule about 1000-fold. Position 2 is defined as a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P3-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVKPYALINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34074</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324677</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 3 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the HLA-A*0301 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324676</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 3 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the Patr A*0101 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P4-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFKYALINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34000</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324678</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 4 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the Patr A*0101 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324679</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 4 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the HLA-A*0301 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P5-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFPKALINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34003</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324680</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 5 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the Patr A*0101 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324681</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 5 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the HLA-A*0301 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P6-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFPYKLINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34014</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324682</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 6 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the Patr A*0101 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324683</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 6 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the HLA-A*0301 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P7-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFPYAKINK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34004</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324684</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 7 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the Patr A*0101 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324685</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 7 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the HLA-A*0301 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P8-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFPYALKNK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34013</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324686</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 8 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the Patr A*0101 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324687</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 8 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the HLA-A*0301 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P9-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFPYALIKK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34005</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324688</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 9 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the Patr A*0101 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324689</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 9 of the prototype peptide (KVPYALINK; 0.7 nM) which has little effect on binding to the HLA-A*0301 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P10-R)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFPYALINR</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34012</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324690</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Arg substitution at position 10 of the prototype peptide (KVPYALINK; 0.7 nM) which increases binding to the Patr A*0101 class I molecule 10-fold. Position 10 is defined as the main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324691</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 10 of the prototype peptide (KVPYALINK; 0.7 nM) which increases binding to the HLA-A*0301 class I molecule &gt;10-fold. Position 10 is defined as the main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P10-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFPYALINA</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34006</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324692</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 10 of the prototype peptide (KVPYALINK; 0.7 nM) which does not affect binding to the Patr A*0101 class I molecule 10-fold. Position 10 is defined as the main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324693</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 10 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the HLA-A*0301 class I molecule 10-fold. Position 10 is defined as the main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P10-L)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFPYALINL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34010</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324695</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 10 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the HLA-A*0301 class I molecule 100-fold. Position 10 is defined as the main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324694</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 10 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the Patr A*0101 class I molecule 10-fold. Position 10 is defined as the main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P10-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFPYALINF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34008</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324697</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 10 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the HLA-A*0301 class I molecule about 1000-fold. Position 10 is defined as the main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324696</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 10 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the Patr A*0101 class I molecule about 100-fold. Position 10 is defined as the main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P10-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFPYALINN</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34011</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324698</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 10 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the Patr A*0101 class I molecule about 1000-fold. Position 10 is defined as the main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324699</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 10 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the HLA-A*0301 class I molecule about 1000-fold. Position 10 is defined as the main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A3Con1 (P10-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KVFPYALIND</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>34007</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A3 supertype peptide A3Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324700</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 10 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the Patr A*0101 class I molecule 1000-fold. Position 10 is defined as the main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>397</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 2</LocationOfData>
                        <MhcBindingId>1324701</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 10 of the prototype peptide (KVPYALINK; 0.7 nM) which decreases binding to the HLA-A*0301 class I molecule about 100-fold. Position 10 is defined as the main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>211</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P1-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KTAVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>33621</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324771</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 1 of the prototype peptide (YTAVVPLVY; 6.4 nM) which reduces binding to the Patr B*0901 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324770</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 1 of the prototype peptide (YTAVVPLVY; 6.4 nM) which reduces binding to the Patr-A*0602 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P2-S)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YSAVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75705</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324791</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Ser substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding slightly to the Patr B*0901 class I molecule. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324792</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Ser substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which does not affect binding to the Patr A*0602 class I molecule. Position 2 is less important as an anchor residue  for Patr A*0602 compared to Patr  B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P2-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YAAVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>73336</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324794</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding slightly to the Patr A*0602 class I molecule.  Position 2 is less important as an anchor residue for Patr A*0602 compared to Patr  B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324793</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule 10-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P2-L)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YLAVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>74571</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324796</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which affects binding slightly to the Patr A*0602 class I molecule. Position 2 is less important as an anchor residue for Patr A*0602 compared to Patr  B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324795</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;100-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P2-M)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YMAVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75035</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324838</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Met substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which affects binding slightly to the Patr A*0602 class I molecule. Position 2 is less important as an anchor residue for Patr A*0602 compared to Patr  B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324837</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Met substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;1000-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P2-I)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YIAVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>74172</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324840</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ile substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;1000-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324839</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ile substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which affects binding slightly to the Patr A*0602 class I molecule. Position 2 is less important as an anchor residue for Patr A*0602 compared to Patr  B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P2-V)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YVAVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>76240</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324842</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Val substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which affects binding slightly to the Patr A*0602 class I molecule. Position 2 is less important as an anchor residue for Patr A*0602 compared to Patr  B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324841</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Val substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;1000-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P2-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YDAVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>73522</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324844</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;100-fold. Position 2 is less important as an anchor residue for Patr A*0602 compared to Patr  B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324843</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;1000-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P2-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YFAVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>73796</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324845</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;1000-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324846</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which affects binding slightly to the Patr A*0602 class I molecule. Position 2 is less important as an anchor residue for Patr A*0602 compared to Patr  B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P2-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YNAVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75132</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324847</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;10-fold. Position 2 is less important as an anchor residue for Patr A*0602 compared to Patr  B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324848</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;1000-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P2-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YKAVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>74429</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324849</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;1000-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324850</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 2 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;10-fold. Position 2 is less important as an anchor residue for Patr A*0602 compared to Patr  B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P3-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTDVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>76007</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324851</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule 10-fold. Position 3 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324852</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding to the Patr B*0901 class I molecule &gt;10-fold. Position 3 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P3-E)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTEVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>76016</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324905</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Glu substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding to the Patr B*0901 class I molecule &lt;10-fold. Position 3 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324906</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Glu substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;100-fold. Position 3 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P3-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTNVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>76140</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324908</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &lt;10-fold. Position 3 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324907</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which affects binding slightly to the Patr B*0901 class I molecule. Position 3 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P3-Q)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTQVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>76166</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324909</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Gln substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which does not affect binding to the Patr B*0901 class I molecule. Position 3 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324910</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Gln substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;10-fold. Position 3 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P3-L)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTLVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>76119</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324912</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &lt;10-fold. Position 3 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324911</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;10-fold. Position 3 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P3-S)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTSVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>76181</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324921</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Ser substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &lt;10-fold. Position 3 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324922</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Ser substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &lt;10-fold. Position 3 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P3-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTFVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>76033</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324923</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;10-fold. Position 3 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324924</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &lt;10-fold. Position 3 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P3-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTKVVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>76102</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324925</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;10-fold. Position 3 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324926</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 3 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule about 1000-fold. Position 3 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P4-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAKVPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75944</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324927</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 4 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324928</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 4 of the prototype peptide (YTAVVPLVY; 6.4 nM) which does not affect binding to the Patr A*0602 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P5-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVKPLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75956</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324957</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 5 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324958</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 5 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P6-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVKLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75960</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324959</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 6 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;10-fold.  Position 6 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324960</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 6 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P6-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVFLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75959</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324961</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 6 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule 10-fold.  Position 6 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P6-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVNLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75962</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324992</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 6 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule 10-fold.  Position 6 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P6-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVALVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75957</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324993</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 6 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;10-fold. Position 6 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P6-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVDLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75958</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324994</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 6 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;10-fold.  Position 6 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P6-L)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVLLVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75961</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1324995</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 6 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;1000-fold.  Position 6 is considered an important anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P7-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPDVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75964</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325015</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 7 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding to the Patr B*0901 class I molecule almost 100-fold.  Position 7 is considered a secondary anchor residue for Patr B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325016</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 7 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;100-fold.  Position 7 is considered an important anchor residue for Patr A*0602.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P7-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPNVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75981</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325024</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 7 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule almost 100-fold.  Position 7 is considered an important anchor residue for Patr A*0602.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325023</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 7 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding to the Patr B*0901 class I molecule &gt;10-fold.  Position 7 is considered a secondary anchor residue for Patr B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P7-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPAVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75963</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325026</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 7 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule about 100-fold.  Position 7 is considered an important anchor residue for Patr A*0602.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325025</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 7 of the prototype peptide (YTAVVPLVY; 6.4 nM) which does not affect binding to the Patr B*0901 class I molecule.  Position 7 is considered a secondary anchor residue for Patr B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P7-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPFVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75965</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325028</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 7 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding slightly to the Patr B*0901 class I molecule.  Position 7 is considered a secondary anchor residue for Patr B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325027</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 7 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;10-fold.  Position 7 is considered an important anchor residue for Patr A*0602.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P7-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPKVY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75966</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325030</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 7 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding to the Patr B*0901 class I molecule almost 100-fold.  Position 7 is considered a secondary anchor residue for Patr B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325029</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 7 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule &gt;100-fold.  Position 6 is considered an important anchor residue for Patr A*0602.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P8-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLKY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75970</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325037</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 8 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule almost 100-fold.  Position 8 is considered a secondary anchor residue for Patr B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325036</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 8 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr A*0602 class I molecule 10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P8-L)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLLY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75971</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325052</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 8 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding to the Patr B*0901 class I molecule 10-fold.  Position 8 is considered a secondary anchor residue for Patr B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P8-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLFY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75969</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325055</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 8 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding to the Patr B*0901 class I molecule &lt;10-fold.  Position 8 is considered a secondary anchor residue for Patr B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P8-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLAY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75967</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325056</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 8 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding to the Patr B*0901 class I molecule &lt;10-fold.  Position 8 is considered a secondary anchor residue for Patr B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P8-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLNY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75972</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325057</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 8 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding to the Patr B*0901 class I molecule &lt;10-fold.  Position 8 is considered a secondary anchor residue for Patr B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P8-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLDY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75968</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325058</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 8 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;10-fold.  Position 8 is considered a secondary anchor residue for Patr B*0901.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P9-W)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLVW</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75979</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325065</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Trp substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;10^4-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325059</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Trp substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding to the Patr B*0901 class I molecule &gt;100-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P9-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLVF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75975</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325069</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;1000-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325068</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding to the Patr B*0901 class I molecule &gt;10-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P9-L)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLVL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75977</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325070</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which increases binding to the Patr B*0901 class I molecule &lt;10-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325071</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;1000-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P9-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLVN</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75978</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325072</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;10^4-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325073</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;10-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P9-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLVD</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75974</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325081</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;1000-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325080</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule almost 100-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P9-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLVA</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75973</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325083</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;100-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325082</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;10-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 102-110 (P9-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>YTAVVPLVK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>75976</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A1 supertype peptide Hu J chain 102-110.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325085</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;1000-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>446</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1325084</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 9 of the prototype peptide (YTAVVPLVY; 6.4 nM) which decreases binding to the Patr B*0901 class I molecule &gt;1000-fold.  Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>405</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P1-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KPRTLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>32870</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325093</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 1 of the prototype peptide (APRTLVYLL; 1.3 nM) which increases binding slightly to the Patr B*1301 class I molecule.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P2-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AARTLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>418</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325096</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 2 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &gt;100-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P2-L)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ALRTLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>2871</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325098</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 2 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &gt;100-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P2-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ADRTLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>764</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325099</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 2 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &gt;1000-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P2-S)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASRTLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>4760</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325100</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Ser substitution at position 2 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule almost 10^4-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P2-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ANRTLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3407</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325107</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 2 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule 10^4-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P2-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AFRTLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>1392</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325108</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 2 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule 10^4-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P2-Q)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AQRTLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>4058</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325109</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Gln substitution at position 2 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule 10^4-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P2-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AKRTLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>2279</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325110</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 2 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule 10^4-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P2-G)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AGRTLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>1672</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325111</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Gly substitution at position 2 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule 10^4-fold. Position 2 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P3-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APKTLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3627</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325112</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 3 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P4-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRKLVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3781</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325121</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 4 of the prototype peptide (APRTLVYLL; 1.3 nM) which increases binding to the Patr B*1301 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P5-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTKVYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3787</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325122</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 5 of the prototype peptide (APRTLVYLL; 1.3 nM) which increases binding to the Patr B*1301 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P6-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLKYLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3788</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325123</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 6 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &gt;10-fold. Position 6 is considered a possible secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P7-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVFLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3791</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325124</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 7 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &lt;10-fold. Position 7 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P7-L)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>APRTLVLLL</LinearSequence>
                        <StartingPosition>5</StartingPosition>
                        <EndingPosition>13</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P01892.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3793</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325127</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 7 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &lt;10-fold. Position 7 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P7-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVNLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3794</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325128</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 7 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &lt;10-fold. Position 7 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P7-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVDLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3790</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325129</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 7 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &gt;10-fold. Position 7 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P7-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVALL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3789</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325130</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 7 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &gt;10-fold. Position 7 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P7-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVKLL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3792</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325131</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 7 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule about 100-fold. Position 7 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P8-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYKL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3795</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325134</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 8 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P9-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3798</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325135</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 9 of the prototype peptide (APRTLVYLL; 1.3 nM) which increases binding slightly to the Patr B*1301 class I molecule. Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P9-M)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3802</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325136</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Met substitution at position 9 of the prototype peptide (APRTLVYLL; 1.3 nM) which increases binding slightly to the Patr B*1301 class I molecule. Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P9-I)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3799</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325137</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ile substitution at position 9 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &lt;10-fold. Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P9-V)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLV</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3806</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325138</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Val substitution at position 9 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule 10-fold. Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P9-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLA</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3796</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325139</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 9 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule  almost 100-fold. Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P9-Y)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3808</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325140</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Tyr substitution at position 9 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule 100-fold. Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P9-W)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLW</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3807</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325141</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Trp substitution at position 9 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule 100-fold. Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P9-T)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLT</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3805</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325142</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Thr substitution at position 9 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &gt;100-fold. Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P9-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLD</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3797</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325143</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 9 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule almost 1000-fold. Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P9-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3800</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325144</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 9 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule 1000-fold. Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P9-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLN</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3803</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325145</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 9 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule 1000-fold. Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Hu J chain 5-13 (P9-Q)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APRTLVYLQ</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3804</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-B7 supertype peptide Hu J chain 5-13.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325146</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Gln substitution at position 9 of the prototype peptide (APRTLVYLL; 1.3 nM) which reduces binding to the Patr B*1301 class I molecule &gt;1000-fold. Position 9 is defined as a main anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>448</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P1-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>KYIDNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>34456</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325148</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 1 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule 10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P2-M)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AMIDNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3106</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325151</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Met substitution at position 2 of the prototype peptide (AYIDNYNKF; 164.4 nM) which increases binding to the Patr A*0701 class I molecule 10-fold. Position 2 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P2-P)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APIDNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3596</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325152</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Pro substitution at position 2 of the prototype peptide (AYIDNYNKF; 164.4 nM) which increases binding to the Patr A*0701 class I molecule 10-fold. Position 2 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P2-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AFIDNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>1314</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325153</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 2 of the prototype peptide (AYIDNYNKF; 164.4 nM) which increases binding slightly to the Patr A*0701 class I molecule. Position 2 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P2-L)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ALIDNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>2620</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325154</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Met substitution at position 2 of the prototype peptide (AYIDNYNKF; 164.4 nM) which increases binding to the Patr A*0701 class I molecule 10-fold. Position 2 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P2-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AAIDNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>217</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325155</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 2 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &gt;10-fold. Position 2 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P2-W)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AWIDNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5664</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325156</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Trp substitution at position 2 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &gt;100-fold. Position 2 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P2-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ANIDNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>3317</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325157</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 2 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule about 100-fold. Position 2 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P2-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ADIDNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>678</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325158</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 2 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &gt;100-fold. Position 2 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P2-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AKIDNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>2203</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325159</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 2 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &gt;100-fold. Position 2 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P3-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYKDNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5849</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325160</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 3 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P4-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIKNYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5816</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325161</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 4 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P5-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDKYNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5796</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325162</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 5 of the prototype peptide (AYIDNYNKF; 164.4 nM) which increases binding to the Patr A*0701 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P6-F)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNFNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5799</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325163</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Phe substitution at position 6 of the prototype peptide (AYIDNYNKF; 164.4 nM) which increases binding to the Patr A*0701 class I molecule about 10-fold. Position 6 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P6-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNANKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5797</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325164</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 6 of the prototype peptide (AYIDNYNKF; 164.4 nM) which increases binding slightly to the Patr A*0701 class I molecule. Position 6 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P6-L)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNLNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5801</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325165</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 6 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &lt;10-fold. Position 6 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P6-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNNNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5802</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325166</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 6 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule almost 10-fold. Position 6 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P6-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNKNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5800</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325167</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 6 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule almost 100-fold. Position 6 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P6-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNDNKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5798</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325168</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 6 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule 100-fold. Position 6 is considered a secondary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P7-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYKKF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5803</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325169</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 7 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P8-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYNDF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5804</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325170</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 8 of the prototype peptide (AYIDNYNKF; 164.4 nM) which increases binding to the Patr A*0701 class I molecule &lt;10-fold.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P9-L)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYNKL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5810</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325171</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Leu substitution at position 9 of the prototype peptide (AYIDNYNKF; 164.4 nM) which increases binding to the Patr A*0701 class I molecule &gt;10-fold. Position 9 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P9-V)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYNKV</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5813</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325252</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Val substitution at position 9 of the prototype peptide (AYIDNYNKF; 164.4 nM) which increases binding to the Patr A*0701 class I molecule 10-fold. Position 9 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P9-A)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYNKA</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5805</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325253</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has an Ala substitution at position 9 of the prototype peptide (AYIDNYNKF; 164.4 nM) which increases binding slightly to the Patr A*0701 class I molecule. Position 9 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P9-M)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYNKM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5811</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325254</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Met substitution at position 9 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &lt;10-fold. Position 9 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P9-I)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYNKI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5808</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325255</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope has a Ile substitution at position 9 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &lt;10-fold. Position 9 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P9-W)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYNKW</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5814</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325256</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Trp substitution at position 9 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &gt;10-fold. Position 9 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P9-Y)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYNKY</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5815</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325257</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Tyr substitution at position 9 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule almost 100-fold. Position 9 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P9-K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYNKK</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5809</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325258</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has a Lys substitution at position 9 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule 100-fold. Position 9 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P9-D)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYNKD</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5806</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325259</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asp substitution at position 9 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &gt;100-fold. Position 9 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A24Con1 (P9-N)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYIDNYNKN</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5812</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide is a single amino acid substituted analogue of the prototype HLA-A24 supertype peptide A24Con1.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 4</LocationOfData>
                        <MhcBindingId>1325260</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>286</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope has an Asn substitution at position 9 of the prototype peptide (AYIDNYNKF; 164.4 nM) which reduces binding to the Patr A*0701 class I molecule &gt;100-fold. Position 9 is defined as a primary anchor residue.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>438</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

